Serum protein binding of nonsteroidal antiinflammatory drugs: A comparative study

被引:71
作者
Borga, O [1 ]
Borga, B [1 ]
机构
[1] US FDA,CTR DRUG EVALUAT & RES,OFF CLIN PHARMACOL & BIOPHARMACEUT,ROCKVILLE,MD 20857
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1997年 / 25卷 / 01期
关键词
NSAIDs; protein binding; serum; unbound fraction; binding site; binding constant; HPLC; ultrafiltration;
D O I
10.1023/A:1025719827072
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The unbound fraction in serum, f(u), is a critical parameter in describing and understanding the pharmacokinetics of NSAIDs. We compared f(u), for 6 different NSAIDs using ultrafiltration of pooled serum at pH 7.4 and 24C. Measurements covered a wide concentration range in order to define binding affinity and number of binding sites. HPLC was used to measure drug concentrations in serum and ultrafiltrate. Direct injection of ultrafiltrate and serum (diluted 250x) permitted quantitation down to approximately 70 nM for most of the NSAIDs, i.e., approximately 15-20 ng/ml. Assuming binding only to albumin, the data were fitted to a model of two classes of binding sites with dissociation constants K1 and K2. The lowest K1 (highest affinity) was found with flurbiprofen, 0.0658 mu M, the highest with ketoprofen, 5.23 mu M, an 80-fold difference. At low drug concentrations, f(u) becomes virtually constant and approaches a lower limit, f(u)(min). The following f(u)(min) values were calculated: diclofenac 0.21%; fenoprofen 0.25%, flurbiprofen 0.022%, ketoprofen 0.52%, naproxen 0.039%, and tolmetin 0.37%. Thus the least bound NSAID, ketoprofen, had a value 24-fold that of the most highly bound, flurbiprofen. The NSAIDs also differed widely with regard to the extent of variation in f(u) within the range of therapeutic concentrations, and hence with regard to their potential as displacers of other drugs.
引用
收藏
页码:63 / 77
页数:15
相关论文
共 38 条
  • [1] PLASMA AND SYNOVIAL-FLUID KINETICS OF FLURBIPROFEN IN RHEUMATOID-ARTHRITIS
    AARONS, L
    SALISBURY, R
    ALAMSIDDIQI, M
    TAYLOR, L
    GRENNAN, DM
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (02) : 155 - 163
  • [2] KINETICS OF DRUG DISPLACEMENT INTERACTIONS
    AARONS, LJ
    ROWLAND, M
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (02): : 181 - 190
  • [3] BLOUIN R, 1993, BRIT J CLIN PHARMACO, V35, P62
  • [4] BINDING OF TRICYCLIC ANTI-DEPRESSANTS AND PERAZINE TO HUMAN-PLASMA METHODOLOGY AND FINDINGS IN NORMALS
    BRINKSCHULTE, M
    BREYERPFAFF, U
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1979, 308 (01) : 1 - 7
  • [5] DICLOFENAC BINDING TO ALBUMIN AND LIPOPROTEINS IN HUMAN-SERUM
    CHAMOUARD, JM
    BARRE, J
    URIEN, S
    HOUIN, G
    TILLEMENT, JP
    [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (10) : 1695 - 1700
  • [6] INVITRO PROTEIN-BINDING OF DICLOFENAC SODIUM IN PLASMA AND SYNOVIAL-FLUID
    CHAN, KKH
    VYAS, KH
    BRANDT, KD
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (02) : 105 - 108
  • [7] PLASMA-PROTEIN BINDING OF KETOPROFEN ENANTIOMERS IN MAN - METHOD DEVELOPMENT AND ITS APPLICATION
    HAYBALL, PJ
    NATION, RL
    BOCHNER, F
    NEWTON, JL
    MASSYWESTROPP, RA
    HAMON, DPG
    [J]. CHIRALITY, 1991, 3 (06) : 460 - 466
  • [8] HUMAN-SERUM AND PLASMA-PROTEIN BINDING OF ENOXIMONE AND ITS SULFOXIDE METABOLITE
    HOOK, RH
    BOXENBAUM, H
    THOMPSON, GA
    OKERHOLM, RA
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (12) : 1012 - 1017
  • [9] HUNDAL O, 1991, FUNDAM CLIN PHARM, V5, P275
  • [10] NAPROXEN FREE PLASMA-CONCENTRATIONS AND UNBOUND FRACTIONS IN PATIENTS WITH OSTEOARTHRITIS - RELATION TO AGE, SEX, EFFICACY, AND ADVERSE EVENTS
    HUNDAL, O
    RUGSTAD, HE
    HUSBY, G
    [J]. THERAPEUTIC DRUG MONITORING, 1991, 13 (06) : 478 - 484